12.9.2016Download Read more
3.8.2016Download Read more
HBM Partners carries out an ongoing analysis of all trade sales of public and private US and European biotech and pharma companies. The latest HBM Pharma/Biotech M&A Report as well as information on M&A transactions since 2005 are available for download:
Report covers new drugs approved by US FDA. The latest report as well as a list of new drug approvals since 2003 are available for download.